Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jhonny Azuaje

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Combinatorial Chemistry & High Throughput Screening|January 26, 2012
Discovery and preliminary SAR of 5-arylidene-2,2-dimethyl-1,3-dioxane- 4,6-diones as platelet aggregation inhibitorsAbdelaziz El Maatougui, Jhonny Azuaje, Alberto Coelho, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2025
Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agentsLyanne Rodríguez, Carlos Rodríguez, Jhonny Azuaje, et al.
Journal of Medicinal Chemistry|January 30, 2016
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist ChemotypesAbdelaziz El Maatougui, Jhonny Azuaje, Manuel González-Gómez, et al.
Journal of Cheminformatics|January 1, 2018
Computer-aided design of multi-target ligands at A<sub>1</sub>R, A<sub>2A</sub>R and PDE10A, key proteins in neurodegenerative diseasesLeen Kalash, Cristina Val, Jhonny Azuaje, et al.
Journal of Medicinal Chemistry|September 27, 2019
Trifluorinated Pyrimidine-Based A<sub>2B</sub> Antagonists: Optimization and Evidence of Stereospecific RecognitionAna Mallo-Abreu, María Majellaro, Willem Jespers, et al.
Journal of Medicinal Chemistry|April 4, 2017
Enantiospecific Recognition at the A<sub>2B</sub> Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylatesCarlos Carbajales, Jhonny Azuaje, Ana Oliveira, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor AntagonistsAbel Crespo, Abdelaziz El Maatougui, Pierfrancesco Biagini, et al.
Journal of Medicinal Chemistry|August 10, 2017
Effect of Nitrogen Atom Substitution in A<sub>3</sub> Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective AntagonistsJhonny Azuaje, Willem Jespers, Vicente Yaziji, et al.
The Journal of Organic Chemistry|January 7, 2015
Integrated Ugi-based assembly of functionally, skeletally, and stereochemically diverse 1,4-benzodiazepin-2-onesJhonny Azuaje, José M Pérez-Rubio, Vicente Yaziji, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 26, 2023
Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugsClaudia Gioé-Gallo, Sandra Ortigueira, José Brea, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Combinatorial Chemistry & High Throughput Screening|January 26, 2012
Discovery and preliminary SAR of 5-arylidene-2,2-dimethyl-1,3-dioxane- 4,6-diones as platelet aggregation inhibitorsAbdelaziz El Maatougui, Jhonny Azuaje, Alberto Coelho, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2025
Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agentsLyanne Rodríguez, Carlos Rodríguez, Jhonny Azuaje, et al.
Journal of Medicinal Chemistry|January 30, 2016
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist ChemotypesAbdelaziz El Maatougui, Jhonny Azuaje, Manuel González-Gómez, et al.
Journal of Cheminformatics|January 1, 2018
Computer-aided design of multi-target ligands at A<sub>1</sub>R, A<sub>2A</sub>R and PDE10A, key proteins in neurodegenerative diseasesLeen Kalash, Cristina Val, Jhonny Azuaje, et al.
Journal of Medicinal Chemistry|September 27, 2019
Trifluorinated Pyrimidine-Based A<sub>2B</sub> Antagonists: Optimization and Evidence of Stereospecific RecognitionAna Mallo-Abreu, María Majellaro, Willem Jespers, et al.
Journal of Medicinal Chemistry|April 4, 2017
Enantiospecific Recognition at the A<sub>2B</sub> Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylatesCarlos Carbajales, Jhonny Azuaje, Ana Oliveira, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor AntagonistsAbel Crespo, Abdelaziz El Maatougui, Pierfrancesco Biagini, et al.
Journal of Medicinal Chemistry|August 10, 2017
Effect of Nitrogen Atom Substitution in A<sub>3</sub> Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective AntagonistsJhonny Azuaje, Willem Jespers, Vicente Yaziji, et al.
The Journal of Organic Chemistry|January 7, 2015
Integrated Ugi-based assembly of functionally, skeletally, and stereochemically diverse 1,4-benzodiazepin-2-onesJhonny Azuaje, José M Pérez-Rubio, Vicente Yaziji, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 26, 2023
Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugsClaudia Gioé-Gallo, Sandra Ortigueira, José Brea, et al.
Pageof 4